Portal


Dr Khasha Ghaffarzadeh
Dr Khasha Ghaffarzadeh
IDTechEx
+44 (0)1223 812300
Email Analyst
Cellink
 

Cellink

Cellink IDTechEx analyst Nadia Tsao interviewed Cellink CEO Erik Gatenholm on April 20, 2017. The company focuses on developing a range of bioinks for 3D bioprinting, and also manufactures several 3D bioprinters. History The company was started in 2015, and formally launched on January 27, 2016. It was the first bioink company in the world. The bioink technology offered by the company is the result of many years of research by Paul Gatenholm's group at Chalmers University of Technology in Gotenburg, Sweden. On November 3, 2016, the company went public on NASDAQ First North. In December 2016, the company released a beta version of their online platform for bioprinting, and in January 2017 the company released the Bio X, a new line of 3D bioprinters for their advanced users. Cellink